About
About Greenbrook TMS Inc
Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, as well as related psychiatric services. As of December 31, 2021, the company operated 94 wholly owned and 55 TMS centers in the commonwealth of Virginia and the States of Maryland, Delaware, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, South Carolina, Michigan, Alaska, Oregon, California, Iowa, and Massachusetts. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.
Visit company website
5 years, 5 months ago
Greenbrook TMS Inc is currently in a long term uptrend where the price is trading 51.5% above its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.8.
Greenbrook TMS Inc's total revenue rose by 41.9% to $12M since the same quarter in the previous year.
Its net income has dropped by 122.6% to $-8M since the same quarter in the previous year.
Finally, its free cash flow grew by 66.6% to $-3M since the same quarter in the previous year.
Based on the above factors, Greenbrook TMS Inc gets an overall score of 4/5.